EUVIMEDEUVIMED entdecken
Kohortenstudie

Association between the Use of Calcimimetics and Vitamin D Receptor Activators and Fracture Risk in Patients Undergoing Maintenance Hemodialysis: A Cohort Study

Chikao Onogi, Yutaka Sugiyama, Yu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, Eri Koshi-Ito, Shoichi Maruyama

Blood Purification · 2026

DOI: 10.1159/000551864 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Blood Purification, 2026. Verfasst von Chikao Onogi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagoya University, Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Calcimimetic Agents, Hyperparathyroidism, Secondary, Receptors, Calcitriol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Secondary hyperparathyroidism is a major complication of maintenance hemodialysis (MHD). Elevated serum parathyroid hormone levels increase fracture risk. We aimed to investigate the association between secondary hyperparathyroidism medication and fracture risk in patients undergoing MHD.

Methods

Patient data from a large medical claims database were used. Patients receiving MHD were divided into untreated, vitamin D receptor activator (VDRA), and calcimimetic groups. The outcome was the first hospitalization due to any fracture. First hospitalization for hip or vertebral fracture was evaluated. Hazard ratios (HRs) were assessed using a weighted Cox proportional hazards model with overlap weights.

Results

A total of 13,238, 4,847, and 5,977 patients comprised the untreated, VDRA, and calcimimetic groups, respectively. The untreated and calcimimetic groups showed a slightly lower incidence risk of any fracture than the VDRA group, although no significant difference was observed (HR, 0.85; 95% confidence interval [CI], 0.66–1.10 and HR, 0.84; 95% CI, 0.64–1.09, for the untreated and calcimimetic groups, respectively). Regarding hip fracture, the calcimimetic group exhibited a similar downward trend compared with any fracture, whereas the untreated group showed an incidence risk comparable with that of the VDRA group (HR, 0.91; 95% CI, 0.62–1.33 and HR, 0.77; 95% CI, 0.50–1.18, for the untreated and calcimimetic groups, respectively). The risk of vertebral fracture showed a downward trend in both groups, with the calcimimetic group exhibiting a significantly lower risk (HR, 0.63; 95% CI, 0.36–1.10 and HR, 0.45; 95% CI, 0.23–0.86, for the untreated and calcimimetic groups, respectively).

Conclusion

Calcimimetic use may reduce fracture incidence in patients undergoing MHD more effectively than VDRA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCalcimimetic AgentsHyperparathyroidism, SecondaryReceptors, CalcitriolFractures, BoneHip FracturesSpinal FracturesHumansFemaleMaleAgedMiddle AgedCohort StudiesRisk FactorsIncidence

Stichwörter der Autor:innen

CalcimimeticsChronic kidney diseaseFractureHemodialysisSecondary hyperparathyroidism

Substanzen

Calcimimetic AgentsReceptors, Calcitriol

Autor:innen und Institutionen

  • Department of Nephrology, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
  • Department of Nephrology, Gife Prefectural Tajimi Hospital, Tajimi, Japan.
  • Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
  • Department of Nephrology, Nagoya University Hospital, Nagoya, Japan.
  • Department of Nephrology, Nagoya University, Graduate School of Medicine, Nagoya, Japan, furu13@med.nagoya-u.ac.jp.

Zitieren

APA

Onogi, C., Sugiyama, Y., Watanabe, Y., Tanaka, A., Furuhashi, K., Koshi-Ito, E., & Maruyama, S. (2026). Association between the Use of Calcimimetics and Vitamin D Receptor Activators and Fracture Risk in Patients Undergoing Maintenance Hemodialysis: A Cohort Study. Blood Purification. https://doi.org/10.1159/000551864

Vancouver

Onogi C, Sugiyama Y, Watanabe Y, Tanaka A, Furuhashi K, Koshi-Ito E, et al. Association between the Use of Calcimimetics and Vitamin D Receptor Activators and Fracture Risk in Patients Undergoing Maintenance Hemodialysis: A Cohort Study. Blood Purification. 2026. doi:10.1159/000551864

BibTeX
@article{Onogi2026,
  author = {Onogi, Chikao and Sugiyama, Yutaka and Watanabe, Yu and Tanaka, Akihito and Furuhashi, Kazuhiro and Koshi-Ito, Eri and Maruyama, Shoichi},
  title = {Association between the Use of Calcimimetics and Vitamin D Receptor Activators and Fracture Risk in Patients Undergoing Maintenance Hemodialysis: A Cohort Study},
  journal = {Blood Purification},
  year = {2026},
  doi = {10.1159/000551864}
}
Kostenlos starten →